Given the distinct functions of HH/GLI signaling within the heterogeneous cellular context of the tumor and its microenvironment, a precise understanding of HH/GLI signaling in the context of gastric cancer is mandatory for the future evaluation of the therapeutic potential of HH/GLI targeting. The gene discussed is GLI1; the disease is gastric cancer.